Table 2.
Number of intra-specific recombinants and of breakpoints in the genome of chiltepin-infecting PepGMV and PHYVV isolates.
Virus | All |
Wild |
Let-standing |
Cultivated |
|||||
---|---|---|---|---|---|---|---|---|---|
Recombinantsa | Breakpointsb | Recombinantsa | Breakpointsb | Recombinantsa | Breakpointsb | Recombinantsa | Breakpointsb | ||
PepGMV | DNA-A | 38% (18/47) | 20 | 63% (12/19) | 16 | 40% (4/10) | 5 | 11% (2/18) | 4 |
DNA-B | 43% (20/47) | 21 | 42% (8/19) | 19 | 50% (5/10) | 14 | 39% (7/18) | 8 | |
Bothc | 57% (27/47) | 41 | 68% (13/19) | 35 | 70% (7/10) | 19 | 39% (7/18) | 12 | |
PHYVV | DNA-A | 14% (6/42) | 5 | 5% (1/19) | 2 | 18% (2/11) | 4 | 25% (3/12) | 3 |
DNA-B | 21% (9/42) | 19 | 21% (4/19) | 10 | 18% (2/11) | 4 | 25% (3/12) | 6 | |
Bothc | 31% (13/42) | 24 | 21% (4/19) | 12 | 27% (3/11) | 8 | 50% (6/12) | 9 |
Virus isolates may have more than one recombinant fragment in the same genomic DNA. The same recombination breakpoint may appear in isolates from different habitats.
aPercentage of recombinant sequences (number of recombinants out of the total number of isolates sequenced).
bNumber of different breakpoints in the recombinant sequences.
cNumber of recombinants in at least one of the genomic DNAs out of the total number of isolates sequenced and the corresponding number of breakpoints.